文献速递乳房整形与再造创面修复美容整形

脱细胞真皮基质文献结局的统计脆弱性:随机对照试验的系统综述

Statistical fragility of outcomes in acellular dermal matrix literature: A systematic review of randomized controlled trials.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-02-11

该系统综述纳入56项报告二分类结局的脱细胞真皮基质随机对照试验共579个结局,计算脆弱指数(FI)与脆弱商(FQ)。总体FI中位数4(3-5)、FQ中位数0.04(0.03-0.07),26%的结局失访人数等于或超过FI,作者认为ADM相关随机对照试验结局统计脆弱,建议今后同时报告FI、FQ与P值。

要点

  • 56项ADM随机对照试验579个结局的FI中位数为4(3-5),FQ为0.04(0.03-0.07)。
  • 101个统计学显著结局的FI中位数为3(1-6),FQ为0.04(0.02-0.08)。
  • 26%的结局失访人数等于或超过FI。

核心结论

  • ADM相关随机对照试验的结局在统计学上是脆弱的,轻微的结局逆转或维持患者随访即可改变结果的显著性。
  • 作者建议未来研究者同时报告FI、FQ与P值,以全面反映ADM文献的稳健性。

研究设计与样本

  • 系统综述,检索PubMed、Embase、SCOPUS、Medline和Cochrane数据库,纳入2003年至今报告二分类分类结局的ADM随机对照试验。
  • 共筛选127项研究,最终纳入56项随机对照试验、579个结局。
  • 计算FI、rFI(影响结局显著性的结局逆转数)和FQ(标准化脆弱性),以中位数报告,并按干预类型进行亚组分析。

主要发现

  • 全部结局的FI中位数为4(3-5),FQ为0.04(0.03-0.07)。
  • 仅101个结局具有统计学显著性,其FI中位数为3(1-6),FQ为0.04(0.02-0.08)。
  • 无统计学显著性结局的FI中位数为4(3-5),FQ为0.04(0.03-0.07)。
  • 26%的结局失访患者数等于或超过FI。
  • 按干预类型分组,FI中位数仅有小幅波动但仍保持低位。

临床怎么用

  • 作者建议未来研究者同时报告FI、FQ与P值,以全面反映ADM文献的稳健性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acellular dermal matrix (ADM) is commonly used in plastic and reconstructive surgery. With the abundance of randomized controlled trials (RCTs) reporting P-values for ADM outcomes, this study used the fragility index (FI), reverse fragility index (rFI), and fragility quotient (FQ) to evaluate the statistical stability of the outcomes in ADM RCTs. METHODS: PubMed, Embase, SCOPUS, Medline, and Cochrane databases were reviewed for ADM RCTs (2003-present) reporting a dichotomous, categorical outcome. FI and rFI (event reversals influencing outcome significance) and FQ (standardized fragility) were calculated and reported as median. Subgroup analysis was performed based on intervention types. RESULTS: Among the 127 studies screened, 56 RCTs with 579 outcomes were included. The median FI stood at 4 (3-5) and FQ was 0.04 (0.03-0.07). Only 101 outcomes were statistically significant with a median FI of 3 (1-6) and FQ of 0.04 (0.02-0.08). The nonsignificant outcomes had a median FI of 4 (3-5) and FQ of 0.04 (0.03-0.07). Notably, 26% of the outcomes had several patients lost to follow up equal to or surpassing the FI. Based on the intervention type, the median FIs showed minor fluctuations but remained low. CONCLUSIONS: Outcomes from ADM-related RCTs were statistically fragile. Slight outcome reversals or maintenance of patient follow-up can alter the significance of results. Therefore, future researchers are recommended to jointly report FI, FQ, and P-values to offer a comprehensive view of the robustness in ADM literature.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Wang A, Kwon D, Kim E, et al. Statistical fragility of outcomes in acellular dermal matrix literature: A systematic review of randomized controlled trials. J Plast Reconstr Aesthet Surg. 2024. PMID: 38432086. doi:10.1016/j.bjps.2024.02.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。